CalciMedica Tumbles as Safety Concerns Halt Trial of Kidney Injury Drug
CalciMedica discontinues Phase 2 KOURAGE trial for acute kidney injury drug Auxora following safety concerns raised by independent committee monitoring the study.
NOTRELOAD AI
FDA Approves Repeat Treatment for iDose TR Glaucoma Implant
Glaukos receives FDA approval allowing patients to receive multiple iDose TR treatments for glaucoma management, expanding treatment options.
Mizuho Upgrades Circle Internet as USDC Gains Momentum on Polymarket
Mizuho upgrades Circle Internet to Neutral with $77 price target, citing USDC activity on Polymarket as a key growth catalyst.
Palladyne AI Stock Surges on U.S. Air Force Contract Win
Palladyne AI shares jumped 47% premarket after winning an Air Force contract to coordinate autonomous systems including satellites using its SwarmOS platform.
FDA Halts REGENXBIO Gene Therapy Trials After Brain Tumor Discovery
REGENXBIO shares drop 32% as FDA places clinical hold on two rare disease gene therapies following brain tumor discovery in trial participant.
Starbucks Brews Up Strong Sales Growth Under CEO Niccol's Turnaround Plan
Starbucks (SBUX) reports 4% global same-store sales growth for Q1, beating expectations as CEO Brian Niccol's turnaround strategy gains momentum with menu simplification and improved store experience.